FABP4 and coronary artery disorder: Experimental animal evidence (reviewed by Xu and Vanhoutte [6]) links circulating levels of the 15 kDa protein A-FABP that can be secreted by adipocytes and macrophages, to cardiovascular diseases and findings in patients link it to the severity of CAD [34] and heart failure [27].